Proto-oncogenic isoform A2 of eukaryotic translation elongation factor eEF1 is a target of miR-663 and miR-744
about
The eEF1A Proteins: At the Crossroads of Oncogenesis, Apoptosis, and Viral InfectionsImpact of Nutrition on Non-Coding RNA Epigenetics in Breast and Gynecological CancerDecrease expression of microRNA-744 promotes cell proliferation by targeting c-Myc in human hepatocellular carcinoma.Regulation of microRNAs by natural agents: new strategies in cancer therapies.Independent overexpression of the subunits of translation elongation factor complex eEF1H in human lung cancer.MicroRNA and mRNA signatures in ischemia reperfusion injury in heart transplantation.MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5.Up-regulation of serum miR-744 predicts poor prognosis in patients with nasopharyngeal carcinomaAPP intracellular domain acts as a transcriptional regulator of miR-663 suppressing neuronal differentiation.Dietary components as epigenetic-regulating agents against cancermiR-663 overexpression induced by endoplasmic reticulum stress modulates hepatocellular carcinoma cell apoptosis via transforming growth factor beta 1.Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancerHow Diet Intervention via Modulation of DNA Damage Response through MicroRNAs May Have an Effect on Cancer Prevention and Aging, an in Silico Study.Increased Serum Level of MicroRNA-663 Is Correlated with Poor Prognosis of Patients with Nasopharyngeal Carcinoma.High expression of MAP7 predicts adverse prognosis in young patients with cytogenetically normal acute myeloid leukemiaRole of 3'-untranslated region translational control in cancer development, diagnostics and treatment.miRNA-320a inhibits tumor proliferation and invasion by targeting c-Myc in human hepatocellular carcinoma.MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling.Clinical Relevance of microRNA Expressions in Breast Cancer Validated Using the Cancer Genome Atlas (TCGA).The bounty of nature for changing the cancer landscape.Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals.Can the chemotherapeutic agents perform anticancer activity through miRNA expression regulation? Proposing a new hypothesis [corrected].Epigenetic modification of miR-663 controls mitochondria-to-nucleus retrograde signaling and tumor progression.Role of MicroRNA Regulation in Obesity-Associated Breast Cancer: Nutritional Perspectives.Regulation of Cell Signaling Pathways and miRNAs by Resveratrol in Different Cancers.Regulatory role of resveratrol, a microRNA-controlling compound, in HNRNPA1 expression, which is associated with poor prognosis in breast cancer.
P2860
Q26825635-60D25ED7-B47A-4A76-B693-B563D0E77E5EQ27016123-3AFEC0F3-3EC2-4CB6-AB35-6586033A4AD2Q33838155-203C30E0-36AC-426E-9CED-CAEFFB3D8C40Q34194495-EBC4DF44-0C28-4242-BDBD-0C1B91AF7316Q34695733-4E6A1F35-26B0-4621-8B57-958072EB0754Q35053280-05558DBC-BC33-4400-9C3A-D54B2E447232Q35955237-1C2FB329-5A94-47A9-BD32-5A0BE31766A1Q36183019-BFDE2DDE-6266-440F-83E8-93969C3415B9Q36347215-7C45FEA3-F048-45E1-8D44-51D12E5B4CDCQ36576975-6570E031-F7EF-45AD-8DF8-E41F805F51ECQ36726137-BA3F759A-4EC1-4293-82D9-C2D0F54FBAA5Q36750985-43682E7F-E3CE-4AAD-92E9-58E60EB5430BQ36939317-9FF74CBF-01F6-401F-BD42-978B292B8327Q37271170-B9677F12-5228-4907-A5BC-81A3DADDDE95Q37298691-6903D214-D60E-4A63-B47D-86C42335A062Q37617262-DF8B4AE4-1E8A-4C95-AA59-834A1E0A8BA0Q37652976-6DF06903-6935-4D60-BDAB-C4AE0F567D3DQ37716420-2E291963-0DBD-497F-B649-9183581056D7Q38647480-380A0F52-5F14-48F5-9621-36BA4F0293AFQ38707912-79CB4B8E-5268-4816-A6A3-5BD5717DE041Q38816103-23B6B453-C3E2-4D75-AB0E-924CF5B06D0CQ41386455-227D33BC-DCB1-4197-BA00-45EB56A032BAQ46275669-87F84B6B-88A1-4661-A74A-C0E766AD2F9EQ48297415-6EC8521C-0BAB-41FB-8363-83CA5B66A617Q55209672-ABFF01CD-8C87-41EF-838C-4F49ECC23442Q55235307-58857E4F-DA76-464C-A243-91786E69B0F0
P2860
Proto-oncogenic isoform A2 of eukaryotic translation elongation factor eEF1 is a target of miR-663 and miR-744
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Proto-oncogenic isoform A2 of ...... target of miR-663 and miR-744
@ast
Proto-oncogenic isoform A2 of ...... target of miR-663 and miR-744
@en
Proto-oncogenic isoform A2 of ...... target of miR-663 and miR-744
@nl
type
label
Proto-oncogenic isoform A2 of ...... target of miR-663 and miR-744
@ast
Proto-oncogenic isoform A2 of ...... target of miR-663 and miR-744
@en
Proto-oncogenic isoform A2 of ...... target of miR-663 and miR-744
@nl
prefLabel
Proto-oncogenic isoform A2 of ...... target of miR-663 and miR-744
@ast
Proto-oncogenic isoform A2 of ...... target of miR-663 and miR-744
@en
Proto-oncogenic isoform A2 of ...... target of miR-663 and miR-744
@nl
P2093
P2860
P50
P3181
P356
P1476
Proto-oncogenic isoform A2 of ...... target of miR-663 and miR-744
@en
P2093
A Vislovukh
C Beldiman
N Gralievska
P2860
P2888
P304
P3181
P356
10.1038/BJC.2013.243
P407
P50
P577
2013-05-21T00:00:00Z
P5875
P6179
1019438484